Effect of Nebivolol on Microalbuminuria in Hypertensive Patients with or without Type 2 Diabetes Mellitus
Padma Latha Merugu1, Thrilok Chander Bingi2★★ Corresponding author
- 1Department of Pharmacology, Kamineni Academy of Medical Sciences and Research Centre, Hyderabad, India.
- 2Department of General Medicine, Gandhi Medical College/Hospital, Secunderabad, Telangana, India.
CORRESPONDENCE
Thrilok Chander Bingi
Flat No: 605, Namita Everest, Bahadurguda, L.B. Nagar, Ranga Reddy, Hyderabad - 500 074, Telangana, India.
Received: 06-10-2019; Revised: 27-12-2019; Accepted: 06-05-2020.
Volume 11, Issue 1 · pp. 13–18 · PUBLISHED 12 September 2020 · DOI: 10.4103/jpp.JPP_95_19
View on J Pharmacol. Pharmacother. original site ↗
ABSTRACT
Objective: To evaluate the effect of nebivolol on microalbuminuria (MA) in hypertensive patients with or without type 2 diabetes mellitus. Materials and Methods: This was an open-label, prospective study. Drug naive patients with stage I hypertension with or without type 2 DM with MA (urine albumin: creatinine ratio [UACR] between 30–300 mg/g) were enrolled in the study and were started on nebivolol 5 mg orally once daily. Efficacy parameters UACR, blood pressure (BP) were measured at baseline and 24 weeks. Paired t-test was used to analyze efficacy endpoints. P < 0.05 was considered to be statistically significant. Results: A total of 30 participants completed the study. Participants who received nebivolol showed a significant decrease in mean UACR, systolic BP, and diastolic BP at 24 weeks compared to baseline (P < 0.001). No participant discontinued the study because of adverse events. Conclusion: Nebivolol has a favorable effect on MA in addition to its antihypertensive effect in hypertensive patients. Further studies with large samples are required to characterize this effect of nebivolol on clinical outcomes.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Merugu, P. L., & Bingi, T. C. (2020). Effect of Nebivolol on Microalbuminuria in Hypertensive Patients with or without Type 2 Diabetes Mellitus. Journal of Pharmacology and Pharmacotherapeutics, 11(1), 13–18. https://doi.org/10.4103/jpp.JPP_95_19
